Colorescience®, a leading dermatologist-recommended skincare company, is pleased to announce the launch of two new additions to its award-winning Total Protection™ Face Shield line of all-mineral sunscreens. New Face Shield Flex SPF 50 ($45) and Face Shield Matte SPF 50 ($39) feature the brand’s proprietary EnviroScreen® Technology to provide comprehensive protection from environmental aggressors.
Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced it has entered into a definitive agreement to sell its miraDry business to 1315 Capital, a healthcare growth equity firm investing in commercial stage companies across medical devices, healthcare services, and therapeutics. Subject to certain terms and …
Verogen Inc. announced today that it is debuting an affordable entry point to NGS on the MiSeq FGx® Sequencing System with the commercial launch of the ForenSeq MainstAY Workflow. The kit targets the core autosomal and Y-STR loci accepted by global databases, minimizing the need to validate additional markers. With two kit sizes and support for volume …
Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) announced today that eviCore Healthcare (“eviCore”), a wholly owned subsidiary of Cigna, has updated their laboratory management guidelines to include positive coverage for ThyGeNEXT® and ThyraMIR®. This update, which impacts approximately 27 health plans nationwide covering 100 million lives, is effective on July 1, 2021. This means …
In celebration of Patient Experience Week (April 26-30, 2021), Onkos Surgical, a leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, today announced ongoing growth and adoption of its patient-centric innovations. These solutions are designed to help improve patient outcomes and experiences using the latest in precision anatomic modeling, 3D printing, design innovation, and …
Interpace Pharma Solutions, a subsidiary of Interpace Biosciences, Inc. (“Interpace” or the “Company”) (OTCQX: IDXG) announced today new capability in advancing RNA biomarker analysis for gene and cell-based therapies. RNAscope® in situ hybridization (ISH) is a new Interpace offering that can visualize, localize, and quantify gene expression within a single assay.
Bonafide, the company pioneering mainstream medical use of drug-free, naturally derived health solutions for menopause, announces today that Dr. Alyssa Dweck will join its team as its Chief Medical Officer. Bonafide’s products are already trusted by over 9,000 unpaid health care professionals – primarily OBGYNs – and 70,000+ women.
Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced today that it has expanded its capabilities to address the orthoplastics market by incorporating its recently introduced Sequel line of external fixators to complement its existing wound debridement and regenerative products …
Aktana, the global leader in intelligent customer engagement for the life sciences industry, announced the release of a dedicated configuration of their AI offering tailored to the needs of emerging and mid-sized biopharma companies. The new Aktana contextual intelligence offering provides commercial teams at any sized organization with the right insights and content at the …
Greenbrook TMS Inc. (TSX: GTMS) (“Greenbrook” or the “Company”) is pleased to announce that its common shares have been approved for listing and trading in U.S. dollar currency on the NASDAQ Stock Market LLC (“NASDAQ”). Trading on the NASDAQ will commence at the start of trading on March 16, 2021 under the symbol “GBNH”. Greenbrook’s …
Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it has received a Health Canada license for the neXus® Ultrasonic Surgical System. This approval confirms that neXus meets the requirements of Health Canada, allowing Misonix to commercialize neXus, along with …
Nutrition21, LLC (“Nutrition21“) has announced the launch of its latest ingredient, Lustriva™, a clinically tested beauty-from-within ingredient that contains Bonded Arginine Silicate (arginine silicon inositol complex) and Magnesium Biotinate (Nutrition21’s proprietary biotin formulation). The latter is a unique combination that significantly increases biotin solubility 40 times more compared to standard D-biotin, which is commonly found …